Comments
Loading...
Contineum Therapeutics (NASDAQ:CTNM) Stock, Earnings Estimates, EPS, And Revenue
Contineum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 11
EPS Estimate
$-0.440
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Contineum Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Contineum Therapeutics (CTNM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $-0.40 | $-0.43 | 6.98 % |
| Q2 | 2024-08-13 | $-0.39 | $-0.35 | -11.4 % |
Contineum Therapeutics (CTNM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?
Contineum Therapeutics (CTNM) is scheduled to report earnings on May 16, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for Contineum Therapeutics (NASDAQ:CTNM)?
The Actual EPS was $-0.40, which beat the estimate of $-0.43.
What were Contineum Therapeutics’s (NASDAQ:CTNM) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.